6/7/24 16:35 | 6/6/24 | KNSA | Kiniksa Pharmaceuticals, Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Quart Barry D | D0 | D | | M.d | 0 | 0.00 | 0 | 4 | 87 | 9 | D | | | | | | | | | | | | | | |
7/3/23 16:15 | 6/29/23 | KNSA | Kiniksa Pharmaceuticals, Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Quart Barry D | D0 | D | | M.d | 0 | 0.00 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
1/17/23 17:36 | 1/13/23 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 20 | 12 | 178 | D | | | | | | | | | | | | | | |
12/1/22 16:16 | 11/29/22 | KNSA | Kiniksa Pharmaceuticals, Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Quart Barry D | D0 | D | | M.d | 35 | 1.59 | 0 | 22 | | 0 | D | | | | | | | | | | | | | | |
12/1/22 16:16 | 11/29/22 | KNSA | Kiniksa Pharmaceuticals, Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Quart Barry D | D0 | D | | S.d | -355 | 16.15 | 0 | -22 | -100 | 0 | D | | | | | | | | | | | | | | |
10/17/22 16:38 | 10/13/22 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 20 | 14 | 162 | D | | | | | | | | | | | | | | |
7/15/22 16:57 | 7/13/22 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 20 | 16 | 147 | D | | | | | | | | | | | | | | |
4/15/22 17:05 | 4/13/22 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 20 | 18 | 131 | D | | | | | | | | | | | | | | |
1/14/22 17:08 | 1/13/22 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 20 | 20 | 117 | D | | | | | | | | | | | | | | |
10/15/21 16:25 | 10/13/21 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 4 | 4 | 102 | D | | | | | | | | | | | | | | |
7/15/21 16:50 | 7/13/21 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 4 | 4 | 99 | D | | | | | | | | | | | | | | |
4/15/21 16:54 | 4/13/21 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 4 | 4 | 95 | M | | | | | | | | | | | | | | |
1/15/21 16:29 | 1/13/21 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 4 | 4 | 92 | D | | | | | | | | | | | | | | |
10/4/19 19:58 | 10/3/19 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | P | 80 | 17.50 | 0 | 5 | 5 | 95 | D | | | | | | | | | | | | | | |
9/14/18 11:41 | 9/14/18 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 142 | 7.20 | 0 | 20 | 28 | 89 | D | | | | | | | | | | | | | | |
6/22/18 21:35 | 6/21/18 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 453 | 9.05 | 0 | 50 | 255 | 70 | D | | | | | | | | | | | | | | |
6/22/18 21:35 | 6/21/18 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | S.d | -1,953 | 39.05 | 0 | -50 | -42 | 70 | D | | | | | | | | | | | | | | |
3/19/18 19:22 | 3/19/18 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 720 | 7.20 | 0 | 100 | | 68 | D | | | | | | | | | | | | | | |
3/19/18 19:22 | 3/19/18 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | S.d | -2,975 | 29.75 | 0 | -100 | -60 | 68 | D | | | | | | | | | | | | | | |
3/16/18 21:00 | 3/14/18 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 720 | 7.20 | 0 | 100 | | 68 | D | | | | | | | | | | | | | | |
3/16/18 21:00 | 3/14/18 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | S.d | -2,475 | 24.75 | 0 | -100 | -60 | 68 | D | | | | | | | | | | | | | | |
7/20/16 08:50 | 7/19/16 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 33 | 7.20 | 8 | 5 | 8 | 66 | D | 76 | -56 | -18 | -30 | -24 | -12 | -16 | -4 | 5 | 5 | 34 | 0 | -19 | |
3/3/16 08:01 | 3/2/16 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 25 | 7.20 | 14 | 3 | 6 | 61 | D | 25 | 36 | -54 | -41 | -13 | -4 | -9 | -5 | 0 | 1 | 18 | 17 | 8 | -19 |
12/30/15 17:13 | 12/28/15 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 17 | 7.20 | 15 | 2 | 3 | 82 | D | 219 | 192 | -6 | 37 | 15 | 7 | 13 | 7 | -5 | -2 | -24 | -31 | -34 | -50 |
10/15/15 08:02 | 10/14/15 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 72 | 7.20 | 33 | 10 | 14 | 80 | D | 233 | 221 | 64 | -33 | -37 | -37 | -13 | -9 | 3 | -1 | 9 | 0 | -10 | -34 |
9/30/15 08:51 | 9/29/15 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 103 | 7.20 | 33 | 14 | 26 | 70 | D | 214 | 143 | 47 | -32 | -34 | -45 | -42 | -42 | 14 | 11 | 31 | 37 | -11 | -17 |
8/19/15 16:39 | 8/18/15 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | M.d | 72 | 7.20 | 15 | 10 | 22 | 56 | D | 313 | 249 | 194 | 157 | 10 | -1 | 2 | 4 | 2 | 2 | 10 | -21 | -43 | -35 |
3/4/15 18:52 | 3/2/15 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | S | -131 | 13.07 | 2 | -10 | -19 | 43 | D | -4 | -8 | 39 | 69 | 63 | 40 | 18 | 3 | 10 | 5 | 1 | 70 | 188 | 29 |
6/26/14 18:48 | 6/25/14 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | P | 118 | 11.75 | 2 | 10 | 19 | 62 | D | -17 | 62 | 35 | -15 | 2 | 8 | 3 | -10 | 0 | 5 | -23 | -28 | -18 | 150 |
6/24/14 17:07 | 6/20/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Quart Barry D | MA | D | | M.d | 34 | 25.00 | 0 | 1 | | 0 | D | | | | | | | | | | | | | | |
6/24/14 17:07 | 6/20/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Quart Barry D | MA | D | | S.d | -138 | 100.00 | 0 | -1 | -100 | 0 | D | | | | | | | | | | | | | | |
6/19/14 17:28 | 6/17/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Quart Barry D | MA | D | | M.d | 24 | 23.95 | 0 | 1 | | 0 | D | | | | | | | | | | | | | | |
6/19/14 17:28 | 6/17/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Quart Barry D | MA | D | | S.d | -90 | 90.00 | 0 | -1 | -100 | 0 | D | | | | | | | | | | | | | | |
6/16/14 18:56 | 6/12/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Quart Barry D | MA | D | | M.d | 23 | 23.00 | 0 | 1 | | 0 | D | | | | | | | | | | | | | | |
6/16/14 18:56 | 6/12/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Quart Barry D | MA | D | | S.d | -83 | 83.31 | 0 | -1 | -100 | 0 | D | | | | | | | | | | | | | | |
11/21/13 15:57 | 11/20/13 | APPA | Ap Pharma Inc /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | P | 400 | 0.4000 | 0 | 1,000 | 999% | 1,037 | D | | | | | | | | | | | | | | |
5/11/11 21:29 | 5/9/11 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | M.d | 78 | 3.90 | 3 | 20 | 47 | 62 | D | 87 | 14 | 13 | 1 | -3 | -1 | -4 | -1 | -1 | -9 | -12 | -36 | -29 | |
5/11/11 21:29 | 5/9/11 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -544 | 27.20 | 3 | -20 | -24 | 62 | D | 87 | 14 | 13 | 1 | -3 | -1 | -4 | -1 | -1 | -9 | -12 | -36 | -29 | |
2/9/11 21:28 | 2/7/11 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | M.dm | 137 | 3.90 | 5 | 35 | 129 | 62 | D | 108 | 84 | 34 | 12 | 1 | 0 | -2 | 0 | 3 | 1 | -1 | 3 | -34 | -27 |
2/9/11 21:28 | 2/7/11 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -535 | 26.77 | 5 | -20 | -24 | 62 | D | 108 | 84 | 34 | 12 | 1 | 0 | -2 | 0 | 3 | 1 | -1 | 3 | -34 | -27 |
12/10/10 21:41 | 12/8/10 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | M.dm | 117 | 3.90 | 2 | 30 | 174 | 47 | D | 146 | 47 | -2 | -4 | 3 | -1 | -1 | -1 | 1 | 14 | 36 | 18 | 4 | -17 |
12/10/10 21:41 | 12/8/10 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -438 | 21.92 | 2 | -20 | -30 | 47 | D | 146 | 47 | -2 | -4 | 3 | -1 | -1 | -1 | 1 | 14 | 36 | 18 | 4 | -17 |
8/10/10 19:39 | 8/9/10 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | M.d | 78 | 3.90 | 2 | 20 | 91 | 42 | D | 46 | 4 | 42 | -6 | -6 | 9 | 6 | -2 | -4 | -6 | 9 | 17 | 33 | -16 |
8/10/10 19:39 | 8/9/10 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -404 | 20.21 | 2 | -20 | -32 | 42 | D | 46 | 4 | 42 | -6 | -6 | 9 | 6 | -2 | -4 | -6 | 9 | 17 | 33 | -16 |
5/7/10 21:50 | 5/7/10 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | M.d | 98 | 3.90 | 6 | 25 | 151 | 42 | D | 69 | 82 | 65 | 55 | 22 | -9 | -10 | -12 | 6 | 13 | 4 | 0 | 8 | 29 |
5/7/10 21:50 | 5/7/10 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -530 | 21.20 | 6 | -25 | -38 | 42 | D | 69 | 82 | 65 | 55 | 22 | -9 | -10 | -12 | 6 | 13 | 4 | 0 | 8 | 29 |
2/10/10 16:30 | 2/8/10 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | M.d | 176 | 3.90 | 1 | 45 | | 42 | D | 3 | 13 | -27 | 7 | 1 | -4 | -1 | 0 | 0 | 0 | 15 | 63 | 37 | 84 |
2/10/10 16:30 | 2/8/10 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -364 | 14.57 | 1 | -25 | -38 | 42 | D | 3 | 13 | -27 | 7 | 1 | -4 | -1 | 0 | 0 | 0 | 15 | 63 | 37 | 84 |
12/11/09 17:09 | 12/9/09 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | M.d | 98 | 3.90 | 2 | 25 | | 22 | D | 9 | 56 | -5 | -21 | 3 | 14 | 2 | -1 | 0 | 3 | 10 | 26 | 59 | 54 |
12/11/09 17:09 | 12/9/09 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -362 | 14.48 | 2 | -25 | -54 | 22 | D | 9 | 56 | -5 | -21 | 3 | 14 | 2 | -1 | 0 | 3 | 10 | 26 | 59 | 54 |
11/10/09 19:48 | 11/9/09 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | M.d | 39 | 3.90 | 1 | 10 | 38 | 37 | D | 62 | 64 | -4 | -29 | -25 | -11 | -2 | 5 | -3 | -2 | 9 | 7 | 80 | 67 |
8/13/09 20:20 | 8/11/09 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | M.dm | 137 | 3.90 | 2 | 35 | | 27 | D | 203 | 40 | 60 | 43 | 26 | 5 | 2 | 4 | -3 | -5 | -12 | -35 | -30 | -8 |
8/13/09 20:20 | 8/11/09 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -483 | 19.33 | 2 | -25 | -49 | 27 | D | 203 | 40 | 60 | 43 | 26 | 5 | 2 | 4 | -3 | -5 | -12 | -35 | -30 | -8 |
5/21/09 21:02 | 5/19/09 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | M.d | 117 | 3.90 | 1 | 30 | | 27 | D | 204 | 8 | 59 | 6 | 63 | 22 | 4 | 5 | 0 | -2 | -2 | 30 | -16 | 48 |
5/21/09 21:02 | 5/19/09 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -385 | 15.39 | 1 | -25 | -49 | 27 | D | 204 | 8 | 59 | 6 | 63 | 22 | 4 | 5 | 0 | -2 | -2 | 30 | -16 | 48 |
9/22/08 14:31 | 9/22/08 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | M.d | 20 | 3.90 | 1 | 5 | 32 | 21 | D | 284 | 60 | 11 | 7 | -2 | 8 | -2 | 1 | -3 | -3 | -17 | -22 | -15 | 25 |
9/4/08 19:26 | 9/3/08 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | M.d | 59 | 3.90 | 0 | 15 | 999% | 16 | D | 285 | 89 | -4 | -6 | 3 | -8 | -9 | -9 | -1 | 5 | -10 | -44 | -24 | 37 |